Progyny, Inc. Non Peo Neo Avg Total Comp Amt
Progyny, Inc. (PGNY) reported Non Peo Neo Avg Total Comp Amt of $2.15 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-10.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-10
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $2.15M DEF 14A · filed 2026-04-10 |
| 2024-12-31 | $6.52M DEF 14A · filed 2026-04-10 |
| 2023-12-31 | $986.13K DEF 14A · filed 2026-04-10 |
| 2022-12-31 | $9.30M DEF 14A · filed 2026-04-10 |
| 2021-12-31 | $5.45M DEF 14A · filed 2026-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |